| scholarly article | Q13442814 |
| editorial | Q871232 |
| P2093 | author name string | Israel F Charo | |
| P2860 | cites work | Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails | Q24310185 |
| CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice | Q28591940 | ||
| Monocyte and macrophage heterogeneity | Q29547438 | ||
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
| The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions | Q29615381 | ||
| Progress and challenges in translating the biology of atherosclerosis | Q29619982 | ||
| The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: analysis and recommendations. On behalf of the Subcommittee on Animal, Cellular and Molecular Models of Thrombosis and Haemostasis of | Q33655834 | ||
| Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells | Q33667974 | ||
| Therapeutic siRNA silencing in inflammatory monocytes in mice | Q35539710 | ||
| Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis | Q35679591 | ||
| The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions | Q35864063 | ||
| Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice | Q36867835 | ||
| Immune and inflammatory mechanisms of atherosclerosis (*) | Q37325024 | ||
| Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal | Q37503524 | ||
| Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT). | Q37561659 | ||
| Monocyte and macrophage dynamics during atherogenesis | Q37890185 | ||
| Molecular imaging in atherosclerosis: FDG PET. | Q38032798 | ||
| Cholesterol efflux: a novel regulator of myelopoiesis and atherogenesis. | Q38053137 | ||
| Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome. | Q38375421 | ||
| Local expression of inflammatory cytokines in human atherosclerotic plaques | Q41531228 | ||
| Coordinating innate immune cells to optimize microbial killing | Q41779494 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation | Q70580552 | ||
| Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice | Q77231603 | ||
| Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region | Q83236917 | ||
| Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) | Q85063666 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2006-2008 | |
| P577 | publication date | 2013-04-24 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Blinding the monocytes to protect the heart | |
| P478 | volume | 127 |
| Q55275182 | Human Gingiva-Derived Mesenchymal Stem Cells Modulate Monocytes/Macrophages and Alleviate Atherosclerosis. |
| Q38477579 | Interaction network analysis revealed biomarkers in myocardial infarction |
| Q35868864 | Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction |
| Q91975849 | Xuezhitong capsule, an extract of Allium macrostemon Bunge, exhibits reverse cholesterol transport and accompanies high-density lipoprotein levels to protect against hyperlipidemia in ApoE-/- mice |
Search more.